Wu Pin, Xiao Hua-Ming, Ding Jun, Deng Qian-Yun, Zheng Fang, Feng Yu-Qi
Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of Education), Department of Chemistry, Wuhan University, Wuhan 430072, PR China.
Key Laboratory of Analytical Chemistry for Biology and Medicine (Ministry of Education), Department of Chemistry, Wuhan University, Wuhan 430072, PR China.
Anal Chim Acta. 2017 Apr 1;960:90-100. doi: 10.1016/j.aca.2017.01.018. Epub 2017 Jan 24.
Quantification of low molecular weight compounds (<800 Da) using matrix assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI MS) is challenging due to the matrix signal interference at low m/z region and poor reproducibility of MS responses. In this study, a C60 labeling-MALDI MS strategy was proposed for the fast, sensitive and reliable determination of amino acids (AAs) in biofluids. An N-hydroxysuccinimide functionalized C60 was synthesized as the labeling reagent and added as an 880 Da tag to AAs; a carboxyl acid containing C60 was employed as the internal standards to normalize MS variations. This solved the inherent problems of MALDI MS for small molecule analysis. The entire analytical procedure-which consisted of simple protein precipitation and 10 min of derivatization in a microwave prior to the MALDI MS analysis-could be accomplished within 20 min with high throughput and great sample matrix tolerance. AA quantification showed good linearity from 0.7 to 70.0 μM with correlation coefficients (R) larger than 0.9954. The limits of detection were 70.0-300.0 fmol. Good reproducibility and reliability of the method were demonstrated by intra-day and inter-day precision with relative standard deviations less than 13.8%, and the recovery in biofluid ranged from 80.4% to 106.8%. This approach could be used in 1 μL of urine, serum, plasma, whole blood, and cerebrospinal fluid. Most importantly, the C60 labeling strategy is a universal approach for MALDI MS analysis of various LMW compounds because functionalized C60 is now available on demand.
由于低质荷比区域的基质信号干扰以及质谱响应的重现性较差,使用基质辅助激光解吸/电离飞行时间质谱(MALDI MS)对低分子量化合物(<800 Da)进行定量分析具有挑战性。在本研究中,提出了一种C60标记-MALDI MS策略,用于快速、灵敏且可靠地测定生物流体中的氨基酸(AA)。合成了一种N-羟基琥珀酰亚胺功能化的C60作为标记试剂,并将其作为880 Da的标签添加到氨基酸中;使用含羧基的C60作为内标来归一化质谱变化。这解决了MALDI MS用于小分子分析的固有问题。整个分析过程包括简单的蛋白质沉淀以及在进行MALDI MS分析之前在微波中进行10分钟的衍生化,可在20分钟内完成,具有高通量和对样品基质的高耐受性。氨基酸定量在0.7至70.0 μM范围内显示出良好的线性,相关系数(R)大于0.9954。检测限为70.0 - 300.0 fmol。日内和日间精密度的相对标准偏差小于13.8%,证明了该方法具有良好的重现性和可靠性,生物流体中的回收率在80.4%至106.8%之间。该方法可用于1 μL的尿液、血清、血浆、全血和脑脊液。最重要的是,C60标记策略是一种用于各种低分子量化合物MALDI MS分析通用方法方法,因为现在可以按需获得功能化的C60。